German Hodgkin's Lymphoma Study Group (DHSG):: 20 years experience with diagnostics, therapy and aftercare in patients with Hodgkin's disease

被引：5

作者：

Ansén, S ^{[1
]}

Engert, A ^{[1
]}

Wolf, J ^{[1
]}

Sieber, M ^{[1
]}

Paulus, U ^{[1
]}

Diehl, V ^{[1
]}

机构：

[1] Univ Cologne, Innere Med Klin 1, D-50924 Cologne, Germany

来源：

ONKOLOGIE | 2001年 / 24卷

关键词：

D O I：

10.1159/000055163

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：35 / 48

页数：14

共 24 条

[1] Lymphocyte-predominant Hodgkin's disease: How little therapy is enough? [J].

Aster, JC .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) :744-746

[2]

BENNETT MH, 1990, PROGR SURG PATHOL, V10, P127

[3] HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS HEMATOPOIETIC RESCUE IN HODGKINS-DISEASE - LONG-TERM FOLLOW-UP IN 128 PATIENTS [J].

BIERMAN, PJ ;

BAGIN, RG ;

JAGANNATH, S ;

VOSE, JM ;

SPITZER, G ;

KESSINGER, A ;

DICKE, KA ;

ARMITAGE, JO .

ANNALS OF ONCOLOGY, 1993, 4 (09) :767-773

[4] ABVD CHEMOTHERAPY IN THE TREATMENT OF HODGKINS-DISEASE [J].

BONADONNA, G ;

SANTORO, A .

CANCER TREATMENT REVIEWS, 1982, 9 (01) :21-35

[5] CHEMOTHERAPY OF ADVANCED HODGKINS-DISEASE WITH MOPP, ABVD, OR MOPP ALTERNATING WITH ABVD [J].

CANELLOS, GP ;

ANDERSON, JR ;

PROPERT, KJ ;

NISSEN, N ;

COOPER, MR ;

HENDERSON, ES ;

GREEN, MR ;

GOTTLIEB, A ;

PETERSON, BA .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) :1478-1484

[6] Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: Report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's disease [J].

Diehl, V ;

Sextro, M ;

Franklin, J ;

Hansmann, ML ;

Harris, N ;

Jaffe, E ;

Poppema, S ;

Harris, M ;

Franssila, K ;

van Krieken, J ;

Marafioti, T ;

Anagnostopoulos, I ;

Stein, H .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) :776-783

[7] BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease [J].

Diehl, V ;

Sieber, M ;

Ruffer, U ;

Lathan, B ;

Hasenclever, D ;

Pfreundschuh, M ;

Loeffler, M ;

Lieberz, D ;

Koch, P ;

Adler, M ;

Tesch, H .

ANNALS OF ONCOLOGY, 1997, 8 (02) :143-148

[8] Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advanced Hodgkin's disease [J].

Diehl, V ;

Loeffler, M ;

Pfreundschuh, M ;

Ruehl, U ;

Hasenclever, D ;

NistersBackes, H ;

Sieber, M ;

Smith, K ;

Tesch, H ;

Geilen, W ;

Adler, M ;

Bartels, H ;

Brandenburg, U ;

Diezler, P ;

Doelken, G ;

Enzian, J ;

Fuchs, R ;

Gassmann, W ;

Gerhartz, H ;

Hagenaukamp, U ;

Hecht, T ;

Hiller, E ;

Hinkelbein, H ;

Lathan, B ;

Kirchner, H ;

Kuehn, G ;

Kuerten, H ;

Loos, U ;

Makoski, B ;

Oertel, W ;

Petsch, S ;

Pfab, R ;

Pflueger, H ;

Planker, M ;

Rohloff, R ;

Sack, H ;

Samandari, S ;

Sauer, R ;

Schalk, K ;

Schmitz, G ;

Schoppe, W ;

Schwieder, G ;

Szepesi, S ;

Teichmann, J ;

Wilhelmy, W ;

Worst, P ;

Fischer, R ;

Georgii, A ;

Huebner, K ;

Schwarze, EW .

ANNALS OF ONCOLOGY, 1995, 6 (09) :901-910

[9] HIGH-DOSE SEQUENTIAL CHEMORADIOTHERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE - A 6-YEAR UPDATE [J].

GIANNI, AM ;

SIENA, S ;

BREGNI, M ;

LOMBARDI, F ;

GANDOLA, L ;

DINICOLA, M ;

MAGNI, M ;

PECCATORI, F ;

VALAGUSSA, P ;

BONADONNA, G .

ANNALS OF ONCOLOGY, 1993, 4 (10) :889-891

[10]

GIANNI AM, 1994, P AN M AM SOC CLIN, V13, P373

← 1 2 3 →